Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of automated bone scan indexes in patients with prostate cancer: aBSI and BONENAVI.

Annals of nuclear medicine·2026
Same author

Preparation and Evaluation of Radiolabeled Porphyrin-Functionalized Lipid Nanodroplets for Cancer Theranostics.

Molecules (Basel, Switzerland)·2026
Same author

High-dose ¹³¹I-metaiodobenzylguanidine therapy in relapsed high-risk neuroblastoma: a descriptive analysis of clinical outcomes and associated factors.

European journal of nuclear medicine and molecular imaging·2026
Same author

Multicenter development and validation of a probability-based model to diagnose Lewy body disease using ¹²³I-meta-iodobenzylguanidine.

European journal of nuclear medicine and molecular imaging·2026
Same author

Clinical applications and future directions of Iodine-131-Metaiodobenzylguanidine therapy in neuroblastoma: from salvage treatment to frontline integration.

Annals of nuclear medicine·2026
Same author

Characteristics of lower limb skeletal muscle activity during walking in patients with knee osteoarthritis and knee extensor weakness: Comprehensive assessment using positron emission tomography.

Journal of electromyography and kinesiology : official journal of the International Society of Electrophysiological Kinesiology·2025

Related Experiment Video

Updated: May 14, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

[Targeted radionuclide therapy - where should we go ?].

Seigo Kinuya1

  • 1Dept. of Nuclear Medicine, Kanazawa University Hospital, Kanazawa, Ishikawa, Japan.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|February 16, 2013
PubMed
Summary

Targeted radionuclide therapy (TRT) uses radiopharmaceuticals to precisely target lesions. Its use is growing, with new agents in clinical trials, addressing current challenges and future potential.

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Radiopharmaceutical Therapy

Context:

  • The application of targeted radionuclide therapy (TRT) is expanding, particularly for differentiated thyroid cancer using radioactive iodine.
  • A novel TRT agent is currently undergoing clinical evaluation, indicating advancements in the field.

Purpose:

  • To discuss the current challenges and limitations associated with targeted radionuclide therapy.
  • To explore the potential future applications and advancements in TRT.

Summary:

  • Targeted radionuclide therapy involves administering radiopharmaceuticals that selectively accumulate in diseased tissues or lesions.
  • The increasing demand for TRT, exemplified by differentiated thyroid cancer treatment, highlights its clinical significance.
  • Ongoing clinical trials for new TRT agents suggest a dynamic and evolving therapeutic landscape.

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

Related Experiment Videos

Last Updated: May 14, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

Impact:

  • Provides insights into the current state and future trajectory of targeted radionuclide therapy.
  • Informs clinicians and researchers about the evolving role of TRT in cancer treatment and beyond.
  • Highlights the need for continued research and development in radiopharmaceutical agents and delivery systems.